We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Briefs.
- Abstract
The article presents new briefs on the biotechnology industries as of 2006. Evotec Technologies was acquired by PerkinElmer in a deal worth $30.5 million. The deal for the acquisition of Inpharmatica in Great Britain by Galapagos in Belgium is expected to be completed in March 2007. Andrew von Eschenbach was confirmed as the U.S. Food and Drug Administration's commissioner.
- Subjects
BIOTECHNOLOGY industries; EVOTEC Technologies GmbH; PERKINELMER Inc.; INPHARMATICA Ltd.; GALAPAGOS NV; VON Eschenbach, Andrew C., 1941-; UNITED States. Food &; Drug Administration
- Publication
Bio-IT World, 2006, Vol 5, Issue 10, p10
- ISSN
1538-5728
- Publication type
Article